BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World J Gastroenterol 2004; 10(3): 427-432 [PMID: 14760772 DOI: 10.3748/wjg.v10.i3.427]
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/427.htm
(0) (0) (8468) (140)
Number Citing Articles
1
Yuki Tanisaka, Masafumi Mizuide, Akashi Fujita, Tomoya Ogawa, Masahiro Suzuki, Hiromune Katsuda, Youichi Saito, Kazuya Miyaguchi, Tomoaki Tashima, Yumi Mashimo, Shomei Ryozawa. Diagnostic Process Using Endoscopy for Biliary Strictures: A Narrative Review. Journal of Clinical Medicine 2021; 10(5) doi: 10.3390/jcm10051048
2
Seung Tai Kim, Joon Oh Park, Jeeyun Lee, Kyu Taek Lee, Jong Kyun Lee, Seong‐Ho Choi, Jin‐Seok Heo, Young Suk Park, Won Ki Kang, Keunchil Park. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 2006; 106(6) doi: 10.1002/cncr.21741
3
Sven H. Loosen, Mihael Vucur, Christian Trautwein, Christoph Roderburg, Tom Luedde. Circulating Biomarkers for Cholangiocarcinoma. Digestive Diseases 2018; 36(4) doi: 10.1159/000488342
4
Wanjin Chen, Shouwen Wang, Hongchuan Zhao, Guobin Wang, Rong Qin, Fan Huang, Wei Geng, Zimei Liu, Wei Wang, Ruolin Wu, Liujin Hou, Zhenghui Ye, Xinghua Zhang, Xiaoping Geng, Xiaojun Yu. High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients. Scandinavian Journal of Gastroenterology 2023; 58(6) doi: 10.1080/00365521.2022.2163184
5
Do Kieu Trang Thoi, Jung Hyun Lim, Jin-Seok Park, Suhyun Park. Deep Learning-assisted Diagnosis of Extrahepatic Common Bile Duct Obstruction Using MRCP Imaging and Clinical Parameters. Current Medical Imaging Formerly Current Medical Imaging Reviews 2025; 21 doi: 10.2174/0115734056363648241215145959
6
Mathew Vithayathil, Shahid A. Khan. Current epidemiology of cholangiocarcinoma in Western countries. Journal of Hepatology 2022; 77(6) doi: 10.1016/j.jhep.2022.07.022
7
Wei-Chun Tsai, Lien-Yu Hung, Teng-Yi Huang, Yen-Shen Shan, Shang-Cheng Hung, Gwo-Bin Lee. A microfluidic system for detection of cholangiocarcinoma cells by using heparan sulfate octasaccharides. 2017 IEEE 12th International Conference on Nano/Micro Engineered and Molecular Systems (NEMS) 2017;  doi: 10.1109/NEMS.2017.8017070
8
Chris Verathamjamras, Churat Weeraphan, Daranee Chokchaichamnankit, Kamolwan Watcharatanyatip, Pantipa Subhasitanont, Penchatr Diskul-Na-Ayudthaya, Kanokwan Mingkwan, Virat Luevisadpaibul, Somchai Chutipongtanate, Voraratt Champattanachai, Jisnuson Svasti, Chantragan Srisomsap. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker. International Journal of Oncology 2017; 51(1) doi: 10.3892/ijo.2017.4024
9
Felix Hahn, Lukas Müller, Florian Jungmann, Aline Mähringer-Kunz, Yasemin Tanyildizi, Christoph Düber, Peter R. Galle, Arndt Weinmann, Roman Kloeckner. Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging. Journal of Cancer Research and Clinical Oncology 2020; 146(7) doi: 10.1007/s00432-020-03200-2
10
Wen-Jing Wang, Wang-Hong Xu, Cha-Zhen Liu, Asif Rashid, Jia-Rong Cheng, Ping Liao, Heng Hu, Lisa W. Chu, Yu-Tang Gao, Kai Yu, Ann W. Hsing. Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers 2010; 2(3) doi: 10.3390/cancers2031602
11
Atit Silsirivanit, Norie Araki, Chaisiri Wongkham, Chawalit Pairojkul, Yoshiki Narimatsu, Kazuhiko Kuwahara, Hisashi Narimatsu, Sopit Wongkham, Nobuo Sakaguchi. A novel serum carbohydrate marker on mucin 5AC. Cancer 2011; 117(15) doi: 10.1002/cncr.25912
12
Sikhakolli Sravan Kumar, Anuj Deshpande, Pooja A. Nair, Suresh Aala, Sunil Chinnadurai, Vineela Chandra Dodda, Inbarasan Muniraj, Md. Abdul Latif Sarker, Hala Mostafa. USSGAN: Unsupervised Spectral and Spatial Attention-Based Generative Adversarial Network for Cholangiocarcinoma Detection. Chemical & Biomedical Imaging 2025; 3(12) doi: 10.1021/cbmi.5c00054
13
Nichol S. Martinez, Arvind J. Trindade, Divyesh V. Sejpal. Determining the Indeterminate Biliary Stricture: Cholangioscopy and Beyond. Current Gastroenterology Reports 2020; 22(12) doi: 10.1007/s11894-020-00797-9
14
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Minshan Chen, Dandan Hu. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery. Journal of Personalized Medicine 2022; 12(12) doi: 10.3390/jpm12122041
15
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binnebösel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann, Tom Luedde. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17175-7
16
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M. Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso. Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 2023; 15(4) doi: 10.3390/cancers15041326
17
Jae Hyun Lee, Dong-Kun Kim, Mi-Yeon Lee, Han-Sol Lim, Min-Jung Kwon, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park. The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults. Nutrients 2023; 15(15) doi: 10.3390/nu15153394
18
Yiannis Petros Dimopoulos, Emily R Winslow, Aiwu Ruth He, Metin Ozdemirli. Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report. World Journal of Clinical Oncology 2021; 12(4): 262-271 doi: 10.5306/wjco.v12.i4.262
19
Rungsun Rerknimitr, Phonthep Angsuwatcharakon, Thawee Ratanachu‐ek, Christopher J L Khor, Ryan Ponnudurai, Jong Ho Moon, Dong Wan Seo, Linda Pantongrag‐Brown, Apichat Sangchan, Pises Pisespongsa, Thawatchai Akaraviputh, Nageshwar D Reddy, Amit Maydeo, Takao Itoi, Nonthalee Pausawasdi, Sundeep Punamiya, Siriboon Attasaranya, Benedict Devereaux, Mohan Ramchandani, Khean‐Lee Goh. Asia–Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2013; 28(4) doi: 10.1111/jgh.12128
20
Remco Kersten, David C. Trampert, Toni Herta, Lowiek M. Hubers, Lucas J. Maillette de Buy Wenniger, Joanne Verheij, Stan F.J. van de Graaf, Ulrich Beuers. IgG4-related cholangitis – a mimicker of fibrosing and malignant cholangiopathies. Journal of Hepatology 2023; 79(6) doi: 10.1016/j.jhep.2023.08.005
21
Lichieh Julie Chu, Chia‐Jung Tsai, Chun‐Chun Chien, Yung‐Chin Hsiao, Jau‐Song Yu, Jun‐Yi Tsai, Ta‐Sen Yeh. Plasma POSTN Derived From Bile Proteome Is a Promising Biomarker for Cholangiocarcinoma With Efficacy Comparable and Complementary to CA19.9. United European Gastroenterology Journal 2025; 13(7) doi: 10.1002/ueg2.70054
22
Hong-Wei Huang, Hao Wang, Chao Leng, Bin Mei. Formation and rupture of liver hematomas caused by intrahepatic gallbladder perforation: A case report and review of literature. World Journal of Gastrointestinal Surgery 2024; 16(10): 3301-3311 doi: 10.4240/wjgs.v16.i10.3301
23
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14090
24
Chisaki Ikeda, Hiroaki Haga, Naohiko Makino, Tatsutoshi Inuzuka, Ayako Kurimoto, Toshiki Ueda, Akiko Matsuda, Yasuharu Kakizaki, Tetsuya Ishizawa, Toshikazu Kobayashi, Shinpei Sugahara, Michihiko Tsunoda, Kensei Suda, Yoshiyuki Ueno. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81023-y
25
Amaar Ghazale, Suresh T. Chari, Lizhi Zhang, Thomas C. Smyrk, Naoki Takahashi, Michael J. Levy, Mark D. Topazian, Jonathan E. Clain, Randall K. Pearson, Bret T. Petersen, Santhi Swaroop Vege, Keith Lindor, Michael B. Farnell. Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy. Gastroenterology 2008; 134(3) doi: 10.1053/j.gastro.2007.12.009
26
Mrinalini Meesala, Muhammad Raza, Avneesh Chhabra, Nilay Mehta, Diwakar Jain. Hepatobiliary abnormalities on nuclear perfusion imaging. Journal of Nuclear Cardiology 2006; 13(2) doi: 10.1007/BF02971254
27
Leva Gorji, Eliza W. Beal. Surgical Treatment of Distal Cholangiocarcinoma. Current Oncology 2022; 29(9) doi: 10.3390/curroncol29090524
28
Chi-Huan Wu, Kai-Feng Sung, Tsung-Hsing Chen, Wei-Pin Lin, Cheng-Yu Lin, Wei-Ting Chen, Yi-Chung Hsieh, Cheng-Jen Chen, Chung-Wei Su, Jennifer Tai, Ming-Ling Chang. The CA19-9/IgG4 ratio distinguishes between cholangiocarcinoma and IgG4-related cholangitis among patients with high IgG4 levels. Asian Journal of Surgery 2026;  doi: 10.1016/j.asjsur.2026.03.226
29
Seungho Lee, Hongbeom Kim, Heeju Sohn, Mirang Lee, Hyesol Jung, Youngjae Jo, Youngmin Han, Wooil Kwon, Jin-Young Jang. The Optimal Cutoff Value of Tumor Markers for Prognosis Prediction in Ampullary Cancer. Cancers 2023; 15(8) doi: 10.3390/cancers15082281
30
Nadine Soliman, Ashton A. Connor, Sudha Kodali, Rafik Mark Ghobrial. Liver Transplantation for Cholangiocarcinoma. Digestive Disease Interventions 2024; 8(04) doi: 10.1055/s-0044-1787171
31
Takashi Kobayashi, Masanori Teruya, Seiichirou Shimizu. Immunoglobulin G4-associated cholangitis. Surgery 2010; 147(5) doi: 10.1016/j.surg.2009.01.001
32
Ningyuan Wen, Yaoqun Wang, Xianze Xiong, Jianrong Xu, Shaofeng Wang, Yuan Tian, Di Zeng, Xingyu Pu, Bei Li, Jiong Lu, Geng Liu, Nansheng Cheng. Integrating Etiological Insights With Machine Learning for Precision Diagnosis of Obstructive Jaundice: Findings From a High-Volume Center. Clinical and Translational Gastroenterology 2025; 16(8) doi: 10.14309/ctg.0000000000000849
33
Adrianne Tsen, Mary Barbara, Laura Rosenkranz. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 2018; 18(8) doi: 10.1016/j.pan.2018.09.004
34
Kitti Intuyod, Napat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, Raynoo Thanan, Somchai Pinlaor. Current omics-based biomarkers for cholangiocarcinoma. Expert Review of Molecular Diagnostics 2019; 19(11) doi: 10.1080/14737159.2019.1673162
35
James Neuberger. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017;  doi: 10.1016/B978-0-323-34062-5.00112-6
36
Amit Singal, Theodore H Welling, Jorge A Marrero. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2009; 9(4) doi: 10.1586/era.09.5
37
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review). International Journal of Oncology 2020;  doi: 10.3892/ijo.2020.5035
38
Qing Wang, Shaoqiong Lu, Ying Chen, Hua He, Weihui Lu, Kanru Lin. Analysis of transcriptome in the relationship between expression of PRC1 protein and prognosis of patients with cholangiocarcinoma. Journal of International Medical Research 2021; 49(3) doi: 10.1177/0300060521989200
39
Sho Yasuta, Motokazu Sugimoto, Masashi Kudo, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10453-2
40
Sikhakolli Sravan Kumar, Omm Prakash Sahoo, Gagan Mundada, Suresh Aala, Dorababu Sudarsa, Om Jee Pandey, Sunil Chinnadurai, Osamu Matoba, Inbarasan Muniraj, Anuj Deshpande. Deep learning-based hyperspectral microscopic imaging for cholangiocarcinoma detection and classification. Optics Continuum 2024; 3(8) doi: 10.1364/OPTCON.527576
41
Bastian Domajnko, Steven A. Ahrendt. Indications for non‐transplant surgery in primary sclerosing cholangitis. HPB 2005; 7(4) doi: 10.1080/13651820500273392
42
Byoung Je Kim, Min Seong Kim, Mi Jeong Kim, Jae Hyuck Yi, Jin Hyuk Paek, Hye Won Lee, Chan Hee Park, Gisu Lee, Koo Jeong Kang. Clinical and Imaging Features of a Focal Intrahepatic Biliary Stricture Visualized Only as Duct Dilatation. Journal of the Korean Society of Radiology 2024; 85(6) doi: 10.3348/jksr.2023.0096
43
Sirintra Udomkitkosol, Pondthip Thaiorn, Phisit Sintusen, Kulthida Vaeteewoottacharn, James R. Ketudat-Cairns, Sumalee Obchoei, Siriporn Proungvitaya, Tin May Aung, Atsushi Kuno, Sayaka Fuseya, Atit Silsirivanit, Sopit Wongkham, Sukanya Luang. Development of a monomeric recombinant Butea monosperma agglutinin as a diagnostic and prognostic biomarker for cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2025; 1869(11) doi: 10.1016/j.bbagen.2025.130852
44
Yu-Ling Chen, Chien-Hung Chen, Rey-Heng Hu, Ming-Chih Ho, Yung-Ming Jeng, Johann Hofmann, David Morris. Elevated Preoperative Serum CA19‐9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/380797
45
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8) doi: 10.18632/oncotarget.13929
46
Hoon Hur, Il-Young Park, Gi-Young Sung, Do-Sang Lee, Wook Kim, Jong-Man Won. Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones. Asian Journal of Surgery 2009; 32(1) doi: 10.1016/S1015-9584(09)60002-6
47
J. NEUBERGER. Surgery of the Liver, Biliary Tract and Pancreas. 2007;  doi: 10.1016/B978-1-4160-3256-4.50123-X
48
Lily V. Saadat, Alice Chia-Chi Wei. Biliary Tract Neoplasms. 2026;  doi: 10.1016/B978-0-443-29287-3.00005-2
49
Jiwen Wang, Xiaojian Ni, Yuxuan Zheng, Song Wang, Hua Bao, Kun Fan, Sheng Shen, Dongqin Zhu, Qingxin Xie, Hairong Bao, Ruowei Yang, Chunyan Wang, Bohao Zheng, Shuang Chang, Xiuxiu Xu, Xiaoling Ni, Tao Suo, Xue Wu, Han Liu, Xiaokun Ma, Houbao Liu. Noninvasive detection and prognostic stratification of biliary tract cancer using cell-free DNA fragmentomics: a model development and validation study. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-026-00468-7
50
Yuanfu Qiu, Jian He, Xinliang Chen, Pinbo Huang, Kaishun Hu, Haiyan Yan. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. Clinica Chimica Acta 2018; 480 doi: 10.1016/j.cca.2018.02.008
51
Yueting Han, Haiyang Zhang, Zhengyang Zhou, Rui Liu, Dongying Liu, Ming Bai, Qian Fan, Jialu Li, Kegan Zhu, Hongli Li, Tao Ning, Guoguang Ying, Yi Ba. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. International Journal of General Medicine 2021;  doi: 10.2147/IJGM.S297371
52
Thomas B. Karasic, Jennifer R. Eads, Lipika Goyal. Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.22.00573
53
Toru Yamada, Yoshitsugu Nakanishi, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Kimitaka Tanaka, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Satoshi Hirano. Impact of serum carbohydrate antigen 19‐9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2018; 33(9) doi: 10.1111/jgh.14124
54
Mazen A. Juratli, Benjamin Struecker, Shadi Katou, M. Haluk Morguel, Andreas Pascher. Einfluss der Molekularpathologie auf die onkologische Chirurgie von Leber- und Gallengangstumoren. Der Chirurg 2021; 92(11) doi: 10.1007/s00104-021-01495-6
55
Marian A. Taulescu, Pompei F. Bolfă, Rareş Buiga, Adrian F. Gal, Bogdan Sevastre, Iancu Morar, Cornel Cătoi. Metastatic cholangiocarcinoma in a llama (Lama glama). Journal of Veterinary Diagnostic Investigation 2012; 24(5) doi: 10.1177/1040638712452110
56
Shoji Kubo, Shigekazu Takemura, Shogo Tanaka, Takayoshi Nishioka, Masahiko Kinoshita, Genya Hamano, Tokuji Ito, Takatsugu Yamamoto, Makoto Abue, Masaru Aoki, Kei Nakagawa, Susumu Hijioka, Atsushi Miyamoto, Yukio Osaki, Ginji Endo, Shinji Kumagai. Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents. Surgery Today 2016; 46(6) doi: 10.1007/s00595-015-1229-9
57
T. Maebayashi, N. Ishibashi, T. Aizawa, M. Sakaguchi, M. Okada. Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II. Cancer/Radiothérapie 2021; 25(3) doi: 10.1016/j.canrad.2020.09.005
58
Wipaporn JARUJAREET, Kensuke TAIRA, Hong Kean OOI. Dynamics of liver enzymes in rabbits experimentally infected with <i>Fasciola</i> sp. (Intermediate form from Japan). Journal of Veterinary Medical Science 2018; 80(1) doi: 10.1292/jvms.17-0315
59
Ali Nada, Alzhraa Alkhatib, Fady Abdelmalik, Mona El-Abd, Naglaa S. Elabd, Hossam El-Din Abdel-Latif. Bile level of cytokeratin 7 as a diagnostic marker for cholangiocarcinoma: a case-control study in Egyptian patients. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00353-4
60
Role of Biomarkers in Cancer Diagnosis and Therapeutics. 2026;  doi: 10.1016/B978-0-443-44041-0.00023-4
61
Maria E. Lozada, Roongruedee Chaiteerakij, Lewis R. Roberts. Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?. Current Hepatology Reports 2015; 14(2) doi: 10.1007/s11901-015-0261-y
62
Wei-Feng Shen, Wei Zhong, Feng Xu, Tong Kan, Li Geng, Feng Xie, Cheng-Jun Sui, Jia-Mei Yang. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(47): 5976-5982 doi: 10.3748/wjg.15.5976
63
Sundeep Singh Saluja, Raju Sharma, Sujoy Pal, Peush Sahni, Tushar Kanti Chattopadhyay. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: A prospective study. HPB 2007; 9(5) doi: 10.1080/13651820701504207
64
Tavan Janvilisri, Kawin Leelawat, Sittiruk Roytrakul, Atchara Paemanee, Rutaiwan Tohtong. Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Disease Markers 2015; 2015 doi: 10.1155/2015/105358
65
Tomoya Kishimoto, Hidetoshi Eguchi, Hiroaki Nagano, Shogo Kobayashi, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Akira Tomokuni, Yoshito Tomimaru, Koji Umeshita, Yuichiro Doki, Masaki Mori. Plasma miR‐21 is a novel diagnostic biomarker for biliary tract cancer. Cancer Science 2013; 104(12) doi: 10.1111/cas.12300
66
Sukanya Luang, Masahiko Minamiya, Nobuo Sakaguchi. Diagnosis and Management of Cholangiocarcinoma. 2021;  doi: 10.1007/978-3-030-70936-5_6
67
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20) doi: 10.3390/cancers15204947
68
Komila Rasuleva, Santhalingam Elamurugan, Aaron Bauer, Mdrakibhasan Khan, Qian Wen, Zhaofan Li, Preston Steen, Ang Guo, Wenjie Xia, Sijo Mathew, Rick Jansen, Dali Sun. β-Sheet Richness of the Circulating Tumor-Derived Extracellular Vesicles for Noninvasive Pancreatic Cancer Screening. ACS Sensors 2021; 6(12) doi: 10.1021/acssensors.1c02022
69
Suparat Cotchim, Supatinee Kongkaew, Panote Thavarungkul, Proespichaya Kanatharana, Warakorn Limbut. A dual-electrode label-free immunosensor based on in situ prepared Au–MoO3-Chi/porous graphene nanoparticles for point-of-care detection of cholangiocarcinoma. Talanta 2024; 272 doi: 10.1016/j.talanta.2024.125755
70
Vor Luvira, Kasama Nilprapha, Vajarabhongsa Bhudhisawasdi, Ake Pugkhem, Nittaya Chamadol, Supot Kamsa-ard. Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study. Asian Pacific Journal of Cancer Prevention 2016; 17(1) doi: 10.7314/APJCP.2016.17.1.401
71
Thomas Gerhardt, Sabine Milz, Michael Schepke, Georg Feldmann, Martin Wolff, Tilman Sauerbruch, Franz Ludwig Dumoulin. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World Journal of Gastroenterology 2006; 12(34): 5495-5500 doi: 10.3748/wjg.v12.i34.5495
72
Kaige YANG, Weiwei WANG, Yan WANG, Chao YAN. Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma. Chinese Journal of Chromatography 2021; 39(11) doi: 10.3724/SP.J.1123.2021.04009
73
Sandra Strainiene, Kotryna Sedleckaite, Juozas Jarasunas, Ilona Savlan, Juozas Stanaitis, Ieva Stundiene, Tomas Strainys, Valentina Liakina, Jonas Valantinas. Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review. World Journal of Clinical Cases 2021; 9(21): 6155-6169 doi: 10.12998/wjcc.v9.i21.6155
74
Chien Peter Chen, Daphne Haas-Kogan. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics. Expert Review of Molecular Diagnostics 2010; 10(7) doi: 10.1586/erm.10.76
75
Takayuki Yamaguchi, Yukihiro Yokoyama, Tomoki Ebata, Atsushi Matsuda, Atsushi Kuno, Yuzuru Ikehara, Junichi Shoda, Hisashi Narimatsu, Masato Nagino. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer. Annals of Surgical Oncology 2016; 23(2) doi: 10.1245/s10434-015-4878-4
76
Nadine Soliman, Anaum Maqsood, Ashton A. Connor. Role of genomics in liver transplantation for cholangiocarcinoma. Current Opinion in Organ Transplantation 2025; 30(2) doi: 10.1097/MOT.0000000000001209
77
Xiao-Fang Liu, Kun Tang, Lu-Lu Sui, Gang Xu. Cholangiocarcinoma: Present Status and Molecular Aspects of Diagnosis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2015; 22(4) doi: 10.3727/096504015X14343704124386
78
Rucksak Rucksaken, Lakhanawan Charoensuk, Porntip Pinlaor, Chawalit Pairojkul, Narong Khuntikeo, Somchai Pinlaor. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma. Cancer Biomarkers 2017; 18(1) doi: 10.3233/CBM-160670
79
Hong Jin Yoon, Sung Ill Jang, Dong Ki Lee. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases. 2020;  doi: 10.1007/978-981-13-0608-2_9
80
Azza Mahmoud El Sheashaey, Marium Nagah Al Zafrany Al Agha, Amr ragab Ibrahim shalaby, Salah Mohammed El Kousy, Gamalate Abd Ellatef Elgedawy. Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00376-x
81
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2) doi: 10.1016/j.suronc.2016.12.009
82
Yu Jin, Qi He, Guochen Shang, Kun Zhang, Chaoqun Han, Gangping Li, Tao Bai, Zhen Ding, Xiaohua Hou. Multimarker Model Enhances Diagnostic Accuracy in Biliary Stricture Determination: Meta-Analysis Validation. Clinical and Translational Gastroenterology 2026; 17(1) doi: 10.14309/ctg.0000000000000936
83
Masakazu Yamamoto, Shun-ichi Ariizumi. Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2006; 41(9) doi: 10.1007/s00535-006-1901-3
84
Olivier Baton, Daniel Azoulay, Delvart V. René Adam, Denis Castaing. Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 and 4: Prognostic Factors and Longterm Outcomes. Journal of the American College of Surgeons 2007; 204(2) doi: 10.1016/j.jamcollsurg.2006.10.028
85
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6) doi: 10.3109/1354750X.2014.923048
86
Apa Juntavee, Banchob Sripa, Ake Pugkhem, Narong Khuntikeo, Sopit Wongkham. Expression of sialyl Lewis<sup>a</sup> relates to poor prognosis in cholangiocarcinoma. World Journal of Gastroenterology 2005; 11(2): 249-254 doi: 10.3748/wjg.v11.i2.249
87
Weizeng Ni, Samuel H. Huang, Qiang Su, Jinghua Shi. Model‐Independent Evaluation of Tumor Markers and a Logistic‐Tree Approach to Diagnostic Decision Support. Journal of Healthcare Engineering 2014; 5(4) doi: 10.1260/2040-2295.5.4.393
88
Perihan El Sayed Salem, Rasha Abdelmawla Ghazala, Ahmed Mohamed El Gendi, Doaa Mokhtar Emara, Nesma Mahmoud Ahmed. The association between circulating MicroRNA‐150 level and cholangiocarcinoma. Journal of Clinical Laboratory Analysis 2020; 34(11) doi: 10.1002/jcla.23397
89
Michela Squadroni, Luca Tondulli, Gemma Gatta, Stefania Mosconi, Giordano Beretta, Roberto Labianca. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2017; 116 doi: 10.1016/j.critrevonc.2016.11.012
90
Sven H. Loosen, Georg Lurje, Georg Wiltberger, Mihael Vucur, Alexander Koch, Jakob N. Kather, Pia Paffenholz, Frank Tacke, Florian T. Ulmer, Christian Trautwein, Tom Luedde, Ulf P. Neumann, Christoph Roderburg, Niklas K. Björkström. Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLOS ONE 2019; 14(1) doi: 10.1371/journal.pone.0210944
91
Jae Hyun Kim, Jeong Hee Yoon, Ijin Joo, Jeong Min Lee. Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI: Pitfalls and Potential Tips. Journal of Magnetic Resonance Imaging 2021; 53(3) doi: 10.1002/jmri.27213
92
M. Ventrucci, P. Pozzato, A. Cipolla, G. Uomo. Persistent elevation of serum CA 19-9 with no evidence of malignant disease. Digestive and Liver Disease 2009; 41(5) doi: 10.1016/j.dld.2008.04.002
93
Ke Zhu, Jin Yang, Ying-zhen Chen, Xue-rong Zhang, Xian-huan Yu, Jie Wang, Rui Zhang, Chao Liu. Differences in Clinical Features and Diagnostic Strategies Between IgG4-Related Autoimmune Cholangitis and Cholangiocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.540904
94
Mehrdad Moghimi, Iraj Ghodosi .. Clinical Efficacy of Combined Use of CEA-CA19-9 in Patients with Pancreatic Malignancy. Journal of Medical Sciences 2007; 7(4) doi: 10.3923/jms.2007.625.629
95
Ji Young Park, Tae Joo Jeon. Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology. Clinical Endoscopy 2019; 52(2) doi: 10.5946/ce.2018.105
96
Toni Herta, Maik Schröder, Dominik Geisel, Cornelius Engelmann, Frank Tacke. Management of IgG4-related cholangitis: diagnosis, therapy, and long-term surveillance. Gastroenterology Report 2025; 13 doi: 10.1093/gastro/goaf032
97
Chun‐Fu Ting, Wen‐Hsin Huang, Chun‐Lung Feng, Cheng‐Ju Yu, Cheng‐Yuan Peng, Wen‐Pang Su, Hsueh‐Chou Lai, Ken‐Sheng Cheng, Po‐Heng Chuang, Jung‐Ta Kao. Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma. Advances in Digestive Medicine 2016; 3(1) doi: 10.1016/j.aidm.2014.12.004
98
Anahita Sadeghi, Mehdi Mohamadnejad, Farhad Islami, Abbas Keshtkar, Mohammad Biglari, Reza Malekzadeh, Mohamad A. Eloubeidi. Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2016; 83(2) doi: 10.1016/j.gie.2015.09.024
99
Juntra Karbwang, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Teerachat Sae-Heng, Panida Kongjam, Inthuon Kulma, Sutthiporn Worrabannakorn, Kesara Na-Bangchang. Exploratory Phase II Study of Atractylodes lancea (Thunb.) DC. in Advanced-Stage Intrahepatic Cholangiocarcinoma. World Journal of Traditional Chinese Medicine 2025; 11(3) doi: 10.4103/wjtcm.wjtcm_7_25
100
Nadine Soliman, David W. Victor, Ashton Anthony Connor. Transplant Oncology. 2025;  doi: 10.1016/B978-0-443-21901-6.00013-6
101
Laura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, Stefan Buettner, Kirsten Utpatel, Heinz-Josef Klümpen, Jorge Adeva, Arndt Vogel, Ana Lleo, Luca Fabris, Mariano Ponz-Sarvise, Raffaele Brustia, Vincenzo Cardinale, Chiara Braconi, Gianpaolo Vidili, Nigel B. Jamieson, Rocio IR. Macias, Jan Philipp Jonas, Marco Marzioni, Wacław Hołówko, Trine Folseraas, Juozas Kupčinskas, Zeno Sparchez, Marcin Krawczyk, Łukasz Krupa, Viorel Scripcariu, Gian Luca Grazi, Ana Landa-Magdalena, Jan NM. Ijzermans, Katja Evert, Joris I. Erdmann, Flora López-López, Anna Saborowski, Alexander Scheiter, Alvaro Santos-Laso, Guido Carpino, Jesper B. Andersen, Jose JG. Marin, Domenico Alvaro, Luis Bujanda, Alejandro Forner, Juan W. Valle, Bas Groot Koerkamp, Jesus M. Banales. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. Journal of Hepatology 2022; 76(5) doi: 10.1016/j.jhep.2021.12.010
102
Waraporn Saentaweesuk, Atit Silsirivanit, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Chawalit Pairojkul, Ubon Cha'on, Somsiri Indramanee, Somchai Pinlaor, Thidarut Boonmars, Norie Araki, Chaisiri Wongkham. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. Clinica Chimica Acta 2018; 477 doi: 10.1016/j.cca.2017.12.005
103
Ramakrishnan Arulraj, James Neuberger. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012;  doi: 10.1016/B978-1-4377-1454-8.00097-7
104
Jang Han Jung, Kyong Joo Lee, Se Woo Park, Dong Hee Koh, Jin Lee. Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions. Journal of Clinical Medicine 2025; 14(19) doi: 10.3390/jcm14196724
105
Akinobu Taketomi, Yoshihiko Maehara. Patient Surveillance After Cancer Treatment. 2013;  doi: 10.1007/978-1-60327-969-7_30
106
Jinjin Cao, Shravya Srinivas-Rao, Nayla Mroueh, Roshni Anand, Sasiprang Kongboonvijit, Madeleine Sertic, Anuradha S. Shenoy-Bhangle, Avinash Kambadakone. Cholangiocarcinoma imaging: from diagnosis to response assessment. Abdominal Radiology 2024; 49(5) doi: 10.1007/s00261-024-04267-y
107
Hyeong Seok Kim, Youngmin Han, Jae Seung Kang, Yoon Hyung Kang, Mirang Lee, Hee Ju Sohn, Hongbeom Kim, Wooil Kwon, Jin-Young Jang. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer. BJS Open 2021; 5(6) doi: 10.1093/bjsopen/zrab127
108
Jia Sun, Chun Li, Zu-Yi Ma, Xin Wu, Tai Liu, Bing-Lu Li. Clinical features, responses to therapy and prognosis of 107 patients with IgG4-related cholangitis: a retrospective study. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-025-04598-0
109
Yun HUANG, Yu XU, Yufang BI, Min XU, Jieli LU, Tiange WANG, Mian LI, Yuhong CHEN, Yu LIU, Fei HUANG, Baihui XU, Jie ZHANG, Weiqing WANG, Guang NING. Relationship between CA 19‐9 levels and glucose regulation in a middle‐aged and elderly Chinese population. Journal of Diabetes 2012; 4(2) doi: 10.1111/j.1753-0407.2011.00179.x
110
Stefania Mosconi, Giordano D. Beretta, Roberto Labianca, Maria G. Zampino, Gemma Gatta, Volker Heinemann. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2009; 69(3) doi: 10.1016/j.critrevonc.2008.09.008
111
Kook Hyun Kim. Diagnostic Approach to Indeterminate Biliary Stricture. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3) doi: 10.15279/kpba.2018.23.3.101
112
Yuki Tanisaka, Masafumi Mizuide, Akashi Fujita, Tomoya Ogawa, Hiromune Katsuda, Youichi Saito, Kazuya Miyaguchi, Ryuhei Jinushi, Rie Terada, Yuya Nakano, Tomoaki Tashima, Yumi Mashimo, Shomei Ryozawa. Current Status of Endoscopic Biliary Drainage in Patients with Distal Malignant Biliary Obstruction. Journal of Clinical Medicine 2021; 10(19) doi: 10.3390/jcm10194619
113
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2. International Journal of Clinical Oncology 2024; 29(5) doi: 10.1007/s10147-024-02497-0
114
L Yang, S Feng, Y Yang. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis. Cancer Gene Therapy 2016; 23(12) doi: 10.1038/cgt.2016.64
115
Antonio Facciorusso, Stefano Francesco Crinò, Paraskevas Gkolfakis, Marco Spadaccini, Marianna Arvanitakis, Torsten Beyna, Michiel Bronswijk, Jahnvi Dhar, Mark Ellrichmann, Rodica Gincul, Istvan Hritz, Leena Kylänpää, Belen Martinez-Moreno, Martina Pezzullo, Mihai Rimbaş, Jayanta Samanta, Roy L.J. van Wanrooij, George Webster, Konstantinos Triantafyllou. Diagnostic work-up of bile duct strictures: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2025; 57(02) doi: 10.1055/a-2481-7048
116
Cherif Boutros, Ponnandai Somasundar, N. Joseph Espat. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009; 18(2) doi: 10.1016/j.soc.2008.12.003
117
Amrita Sethi, Douglas A. Howell. Clinical Gastrointestinal Endoscopy. 2019;  doi: 10.1016/B978-0-323-41509-5.00060-8
118
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Alessandra Rando, Mario Uccello, Francesco Basile, Antonio Biondi, Santo Carnazzo, Innocenza Alessandria, Clorinda Mazzarino. Markers of bile duct tumors. World Journal of Gastrointestinal Oncology 2011; 3(4): 49-59 doi: 10.4251/wjgo.v3.i4.49
119
Margaret Wheless, Rajiv Agarwal, Laura Goff, Natalie Lockney, Chandrasekhar Padmanabhan, Thatcher Heumann. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma. Current Treatment Options in Oncology 2024; 25(1) doi: 10.1007/s11864-023-01153-5
120
Shaurya Dhingra, Puneet Raman, Taylor Ramsaroop, Isaiah Harrison, Tova Bergsten, Erin Nusbaum, Lawrence E. Feldman. Elevated serum CA 19–9 level mimicking pancreaticobiliary carcinoma from a hepatic abscess: case report and literature review. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1470046
121
Siddinath Gyawali, Biraj Pokhrel, Pratik Uprety, Arun Gnawali. IgG4‐related sclerosing cholangitis, a mimicker of the cholangiocarcinoma: A case report. Clinical Case Reports 2023; 11(2) doi: 10.1002/ccr3.6935
122
Sayan Malakar, Sanjit Kumar, Akash Roy, Suprabhat Giri, Sumit Rungta, Mayank Agarwal, Amandeep Singh, Nitesh Bassi, Arghya Samanta, Uday C. Ghoshal, Virendra Singh. Overlap syndromes and associated immunoglobulin-G4-related liver diseases. Journal of Clinical and Experimental Hepatology 2026;  doi: 10.1016/j.jceh.2026.103564
123
Rucksak Rucksaken, Chawalit Pairojkul, Porntip Pinlaor, Narong Khuntikeo, Sittiruk Roytrakul, Carlo Selmi, Somchai Pinlaor, Gabriele Multhoff. Plasma Autoantibodies against Heat Shock Protein 70, Enolase 1 and Ribonuclease/Angiogenin Inhibitor 1 as Potential Biomarkers for Cholangiocarcinoma. PLoS ONE 2014; 9(7) doi: 10.1371/journal.pone.0103259
124
Clotilde Della Pina, Erika Rocchi, Andrea Conti, Sara Montagnani, Laura Crocetti. Focal Liver Lesions. Medical Radiology 2005;  doi: 10.1007/3-540-26354-3_14
125
He Wen, Sung Soo Yoo, Jinho Kang, Hee Goo Kim, Jin-Seok Park, Seok Jeong, Jung Il Lee, Hyuk Nam Kwon, Sunmi Kang, Don-Haeng Lee, Sunghyouk Park. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. Journal of Hepatology 2010; 52(2) doi: 10.1016/j.jhep.2009.11.002
126
Satoru Suzuki, Jun-ichirou Mori, Masanori Yamazaki, Ai Sato, Waki Hosoda, Kiyoshi Hashizume. Beneficial Effects of Pioglitazone on Cholangiohepatitis Induced by Bile Duct Carcinoma. Internal Medicine 2007; 46(20) doi: 10.2169/internalmedicine.46.0312
127
Lisa Heinrichs, Georg Fluegen, Sven H. Loosen, Christina Loberg, Linda Wittig, Alexander Quaas, Patrick S. Plum, Nils Große Hokamp, Peter Minko, Andreas Krieg, Gerald Antoch, Wolfram T. Knoefel, Tom Luedde, Christoph Roderburg, Markus S. Jördens. Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00094-2
128
Rossana Berardi, Federico Mocchegiani, Chiara Pierantoni, Alen Federici, Daniele Nicolini, Francesca Morgese, Azzurra Onofri, Andrea Risaliti, Marco Vivarelli, Stefano Cascinu. Resected biliary tract cancers: A novel clinical–pathological score correlates with global outcome. Digestive and Liver Disease 2013; 45(1) doi: 10.1016/j.dld.2012.08.012
129
Anastasios Gkountakos, Filippo M. Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo, Elena Bariani, Michele Milella, Matteo Fassan, Aldo Scarpa, Claudio Luchini. Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment. Cancers 2023; 15(5) doi: 10.3390/cancers15051454
130
Hiroaki Okuda, Keiko Shiratori, Masakazu Yamamoto, Ken Takasaki, Masayuki Nakano. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for α‐fetoprotein‐L3 and those with combined hepatocellular and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2006; 21(5) doi: 10.1111/j.1440-1746.2006.04257.x
131
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature. The American Journal of the Medical Sciences 2022; 364(3) doi: 10.1016/j.amjms.2022.04.016
132
Sirorat Pattanapairoj, Atit Silsirivanit, Kanha Muisuk, Wunchana Seubwai, Ubon Cha'on, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Danaipong Chetchotsak, Sopit Wongkham. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. Clinical Biochemistry 2015; 48(10-11) doi: 10.1016/j.clinbiochem.2015.03.022
133
Hai-Jie Hu, Hui Mao, Yong-Qiong Tan, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Nan-Sheng Cheng, Fu-Yu Li. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2181-x
134
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA Profiling for Diagnosis, Prognosis and Stratification of Cancer Treatment in Cholangiocarcinoma. Pharmacogenomics 2017; 18(14) doi: 10.2217/pgs-2017-0010
135
Soo Young Jang, Jin Sil Kim, Seung Yon Baek, Hye Ah Lee, Jeong Kyong Lee. Proposed nomogram predicting neoplastic ampullary obstruction in patients with a suspected ampulla of Vater lesion on CT. Abdominal Radiology 2021; 46(7) doi: 10.1007/s00261-021-02975-3
136
Liqiang Qian, Gang Wang, Bin Li, Haoyuan Su, Lei Qin. Regulation of lipid metabolism by APOE4 in intrahepatic cholangiocarcinoma via the enhancement of ABCA1 membrane expression. PeerJ 2024; 12 doi: 10.7717/peerj.16740
137
Mrinalini Meesala, Muhammad Raza, Avneesh Chhabra, Nilay Mehta, Diwakar Jain. Hepatobiliary abnormalities on nuclear perfusion imaging. Journal of Nuclear Cardiology 2006; 13(2) doi: 10.1016/j.nuclcard.2006.01.008
138
T. Clark Gamblin, A.M. Krasinskas, A.S. Slivka, M.E. Tublin, Jake Demetris, Eveline Shue, Susan Caro, J. Wallis Marsh, A. James Moser. Fibroinflammatory Biliary Stricture: A Rare Bile Duct Lesion Masquerading as Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2009; 13(4) doi: 10.1007/s11605-008-0750-1
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.